Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Pyxis Oncology (PYXS) Institutional Ownership

Pyxis Oncology logo
$1.94 -0.06 (-2.75%)
Closing price 03:59 PM Eastern
Extended Trading
$1.94 -0.01 (-0.51%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Pyxis Oncology (NASDAQ:PYXS)

Current
Institutional Ownership
Percentage
39.07%
Number of
Institutional Buyers
(last 12 months)
38
Total
Institutional Inflows
(last 12 months)
$10.13M
Number of
Institutional Sellers
(last 12 months)
14
Total
Institutional Outflows
(last 12 months)
$8.71M
Get PYXS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pyxis Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PYXS Institutional Buying and Selling by Quarter

Pyxis Oncology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/21/2026 J. Derek Lewis & Associates Inc.43,000$63K0.0%-18.9%0.068%
5/19/2026 Bank of America Corp DE16,807$25K0.0%-97.1%0.027%
5/14/2026 Renaissance Technologies LLC888,680$1.30M0.0%+22.0%1.414%
5/7/2026 Dimensional Fund Advisors LP25,912$38K0.0%-48.2%0.041%
5/5/2026 Bank of New York Mellon Corp133,996$196K0.0%-18.8%0.213%
3/23/2026 J. Derek Lewis & Associates Inc.53,000$61K0.0%N/A0.085%
2/18/2026 XTX Topco Ltd289,033$332K0.0%+1,533.0%0.464%
2/18/2026 Toronto Dominion Bank75,000$86K0.0%N/A0.120%
2/18/2026 Quadrature Capital Ltd100,536$116K0.0%N/A0.161%
2/18/2026 Millennium Management LLC743,107$855K0.0%-8.9%1.194%
2/18/2026 Maia Wealth LLC21,959$25K0.0%N/A0.035%
2/18/2026 Engineers Gate Manager LP22,816$26K0.0%N/A0.037%
2/18/2026 683 Capital Management LLC891,910$1.03M0.0%+69.9%1.433%
2/17/2026 Laurion Capital Management LP4,796,479$5.52M0.2%+32.3%7.703%
2/17/2026 ExodusPoint Capital Management LP317,769$365K0.0%N/A0.510%
2/17/2026 Royal Bank of Canada55,551$64K0.0%-28.8%0.089%
2/17/2026 Graham Capital Management L.P.183,942$212K0.0%N/A0.295%
2/16/2026 OMERS ADMINISTRATION Corp67,000$77K0.0%N/A0.108%
2/16/2026 Barclays PLC60,385$69K0.0%+1,939.3%0.097%
2/13/2026 Marshall Wace LLP389,764$448K0.0%N/A0.626%
2/13/2026 Velan Capital Investment Management LP40,000$46K0.0%-27.3%0.064%
2/13/2026 State Street Corp241,637$278K0.0%+19.6%0.388%
2/12/2026 Jane Street Group LLC786,010$904K0.0%+158.8%1.262%
2/12/2026 HRT Financial LP39,649$45K0.0%+157.5%0.064%
2/12/2026 Commonwealth Equity Services LLC39,755$46K0.0%-35.0%0.064%
2/12/2026 Renaissance Technologies LLC728,380$838K0.0%+26.4%1.170%
2/12/2026 Dimensional Fund Advisors LP50,066$58K0.0%+37.1%0.080%
2/11/2026 Fox Run Management L.L.C.22,566$26K0.0%N/A0.036%
2/11/2026 LPL Financial LLC35,102$40K0.0%+150.7%0.056%
2/10/2026 Goldman Sachs Group Inc.86,145$99K0.0%-31.3%0.138%
2/9/2026 Geode Capital Management LLC577,211$664K0.0%+6.0%0.927%
2/6/2026 Atle Fund Management AB617,245$710K0.2%N/A0.991%
1/12/2026 Avanza Fonder AB27,345$31K0.0%N/A0.044%
11/17/2025 Jacobs Levy Equity Management Inc.60,333$134K0.0%N/A0.097%
11/17/2025 Velan Capital Investment Management LP55,000$122K0.1%+37.5%0.088%
11/17/2025 Qube Research & Technologies Ltd30,808$68K0.0%-70.1%0.049%
11/17/2025 Millennium Management LLC815,331$1.81M0.0%-77.0%1.309%
11/17/2025 Citadel Advisors LLC337,359$749K0.0%N/A0.542%
11/17/2025 Bank of America Corp DE615,922$1.37M0.0%+2,690.9%0.989%
11/14/2025 Longaeva Partners L.P.503,214$1.12M0.2%N/A0.808%
I was right about SpaceX (Ad)

Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel

See how to claim your stake in SpaceX before the public can
11/14/2025 Two Sigma Investments LP46,501$103K0.0%N/A0.075%
11/14/2025 Bridgeway Capital Management LLC76,700$170K0.0%-46.1%0.123%
11/13/2025 UBS Group AG373,727$830K0.0%-5.6%0.600%
11/10/2025 Persistent Asset Partners Ltd34,632$77K0.1%N/A0.056%
11/7/2025Vanguard Group Inc.2,163,962$4.80M0.0%+0.7%3.476%
10/31/2025 Pier 88 Investment Partners LLC151,730$337K0.1%-58.7%0.245%
8/15/2025 Bridgeway Capital Management LLC142,295$157K0.0%+76.1%0.230%
8/14/2025 Jane Street Group LLC336,084$370K0.0%N/A0.543%
8/14/2025 Velan Capital Investment Management LP40,000$44K0.0%N/A0.065%
8/14/2025 Qube Research & Technologies Ltd103,063$113K0.0%+128.4%0.166%
8/13/2025 Marshall Wace LLP147,771$163K0.0%N/A0.239%
8/12/2025 XTX Topco Ltd36,380$40K0.0%N/A0.059%
8/12/2025 Catalyst Funds Management Pty Ltd23,200$26K0.0%N/A0.037%
8/8/2025 Geode Capital Management LLC510,963$562K0.0%-53.9%0.825%
8/7/2025 Pier 88 Investment Partners LLC367,170$404K0.1%-6.1%0.593%
8/1/2025 Y Intercept Hong Kong Ltd133,047$146K0.0%N/A0.215%
7/30/2025 Schulhoff & Co. Inc.275,000$302K0.1%+125.4%0.444%
7/11/2025 Kingstone Capital Partners Texas LLC33,600$37K0.0%N/A0.054%
6/27/2025 Goldman Sachs Group Inc.160,830$158K0.0%-12.9%0.260%
5/21/2025Acadian Asset Management LLC84,122$81K0.0%N/A0.136%
5/16/2025Goldman Sachs Group Inc.160,830$158K0.0%-12.9%0.260%
5/16/2025AQR Capital Management LLC40,270$39K0.0%-19.6%0.065%
5/16/2025683 Capital Management LLC550,000$539K0.0%+32.5%0.888%
5/13/2025American Century Companies Inc.26,353$26K0.0%-91.2%0.043%
5/12/2025Nuveen LLC127,304$125K0.0%N/A0.206%
5/9/2025Charles Schwab Investment Management Inc.115,237$113K0.0%-11.2%0.186%
5/6/2025Pier 88 Investment Partners LLC390,960$383K0.1%+296.6%0.631%
2/17/2025Ridgeback Capital Investments L.P.359,231$560K100.0%N/A0.604%
2/17/2025ProShare Advisors LLC16,568$26K0.0%N/A0.028%
2/17/2025Nuveen Asset Management LLC127,304$199K0.0%-14.6%0.214%
2/17/2025OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC146,400$228K0.0%N/A0.246%
2/17/2025Millennium Management LLC2,980,906$4.65M0.0%+53.8%5.012%
2/17/2025Jacobs Levy Equity Management Inc.601,940$939K0.0%+57.2%1.012%
2/17/2025Graham Capital Management L.P.30,287$47K0.0%N/A0.051%
2/17/2025Deutsche Bank AG30,300$47K0.0%-87.3%0.051%
2/17/2025Caption Management LLC22,306$35K0.0%N/A0.038%
2/17/2025Bank of America Corp DE53,745$84K0.0%+20.3%0.090%
2/17/2025Ameriprise Financial Inc.22,251$35K0.0%N/A0.037%
2/14/2025Jane Street Group LLC67,686$106K0.0%+36.6%0.114%
2/14/2025Northern Trust Corp378,586$591K0.0%-3.9%0.637%
2/14/2025Boothbay Fund Management LLC181,042$282K0.0%-52.7%0.304%
2/14/2025Dimensional Fund Advisors LP111,051$173K0.0%+35.5%0.187%
2/13/2025Marshall Wace LLP157,953$246K0.0%+35.7%0.266%
2/13/2025XTX Topco Ltd22,492$35K0.0%-73.5%0.038%
2/13/2025Barclays PLC77,013$121K0.0%+20.2%0.129%
2/13/2025Renaissance Technologies LLC293,354$458K0.0%+83.0%0.493%
2/13/2025Aristides Capital LLC124,000$193K0.0%N/A0.209%
2/12/2025Pier 88 Investment Partners LLC98,590$154K0.0%-18.9%0.166%
2/11/2025Sei Investments Co.61,140$95K0.0%N/A0.103%
2/11/2025American Century Companies Inc.299,937$468K0.0%+88.1%0.504%
Your book is inside (Ad)

The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel

2/10/2025Commonwealth Equity Services LLC26,250$41K0.0%+61.5%0.044%
11/19/2024Barclays PLC64,089$235K0.0%+275.0%0.108%
11/16/2024Geode Capital Management LLC1,084,727$3.98M0.0%+5.5%1.824%
11/15/2024Barclays PLC64,089$235K0.0%+275.0%0.108%
11/15/2024Public Employees Retirement System of Ohio29,100$107K0.0%N/A0.049%
11/15/2024XTX Topco Ltd84,771$311K0.0%+133.6%0.143%
11/15/2024Jane Street Group LLC49,558$182K0.0%+40.8%0.083%
11/15/2024State Street Corp951,251$3.49M0.0%+28.0%1.600%
11/15/2024Jacobs Levy Equity Management Inc.382,840$1.41M0.0%N/A0.644%
11/14/2024MetLife Investment Management LLC18,818$69K0.0%+41.1%0.032%


PYXS Institutional Ownership - Frequently Asked Questions

During the previous two years, 73 institutional investors and hedge funds held shares of Pyxis Oncology. The most heavily invested institutionals were Laurion Capital Management LP ($5.52M), Vanguard Group Inc. ($4.80M), Blue Owl Capital Holdings LP ($3.46M), abrdn plc ($3.35M), Renaissance Technologies LLC ($1.30M), Longaeva Partners L.P. ($1.12M), and 683 Capital Management LLC ($1.03M).Learn more on Pyxis Oncology's institutional investors.

39.07% of Pyxis Oncology's stock is owned by institutional investors. Learn more on PYXS's institutional investor holdings.

Of the 62 institutional investors that purchased Pyxis Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Millennium Management LLC ($1.79M), Laurion Capital Management LP ($1.17M), Blue Owl Capital Holdings LP ($1.05M), Jane Street Group LLC ($850.87K), Jacobs Levy Equity Management Inc. ($662.27K), Atle Fund Management AB ($617.25K), and Bank of America Corp DE ($602.92K).

Institutional investors have bought a total of 7,318,930 shares in the last 24 months. This purchase volume represents approximately $10.13M in transactions.

Of the 13 institutional investors that sold Pyxis Oncology's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Millennium Management LLC ($2.80M), Geode Capital Management LLC ($598.14K), Bank of America Corp DE ($571.04K), Pier 88 Investment Partners LLC ($239.23K), Qube Research & Technologies Ltd ($72.26K), Bridgeway Capital Management LLC ($65.60K), and Goldman Sachs Group Inc. ($63.18K).

Institutional investors have sold a total of 4,542,593 shares in the last 24 months. This volume of shares sold represents approximately $8.70M in transactions.



This page (NASDAQ:PYXS) was last updated on 5/21/2026 by MarketBeat.com Staff.
From Our Partners